Moreno S - Search Results

1

Selective miRNA inhibition in CD8⁺ cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses.

Madrid-Elena N, Serrano-Villar S, Gutiérrez C, Sastre B, Morín M, Luna L, Martín L, Santoyo-López J, López-Huertas MR, Moreno E, García-Bermejo ML, Moreno-Pelayo MÁ, Moreno S. Madrid-Elena N, et al. Among authors: moreno pelayo ma, moreno e, moreno s. Front Immunol. 2022 Sep 26;13:998368. doi: 10.3389/fimmu.2022.998368. eCollection 2022. Front Immunol. 2022. PMID: 36225912 Free PMC article.

2

High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir.

Pérez-Elías MJ, Moreno S, Gutiérrez C, López D, Abraira V, Moreno A, Dronda F, Casado JL, Antela A, Rodríguez MA. Pérez-Elías MJ, et al. Among authors: moreno s, moreno a. AIDS. 2005 Apr 29;19(7):695-8. doi: 10.1097/01.aids.0000166092.39317.42. AIDS. 2005. PMID: 15821395 Clinical Trial.

3

Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.

Pérez-Elías MJ, Moreno A, Moreno S, López D, Antela A, Casado JL, Dronda F, Gutiérrez C, Quereda C, Navas E, Abraira V, Rodríguez MA. Pérez-Elías MJ, et al. Among authors: moreno s, moreno a. HIV Clin Trials. 2005 Nov-Dec;6(6):312-9. doi: 10.1310/B3NK-V5XQ-6VX9-5DEK. HIV Clin Trials. 2005. PMID: 16452065 Clinical Trial.

4

[Maraviroc efficacy in clinical studies on the development of the molecule].

Moreno S, Hernández B, Gutiérrez C, Delsol E. Moreno S, et al. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:17-22. doi: 10.1016/s0213-005x(08)76559-5. Enferm Infecc Microbiol Clin. 2008. PMID: 19133217 Review. Spanish.

5

Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected.

Gutiérrez C, Díaz L, Vallejo A, Hernández-Novoa B, Abad M, Madrid N, Dahl V, Rubio R, Moreno AM, Dronda F, Casado JL, Navas E, Pérez-Elías MJ, Zamora J, Palmer S, Muñoz E, Muñoz-Fernández MÁ, Moreno S. Gutiérrez C, et al. Among authors: moreno am, moreno s. PLoS One. 2011;6(12):e27864. doi: 10.1371/journal.pone.0027864. Epub 2011 Dec 8. PLoS One. 2011. PMID: 22174752 Free PMC article. Clinical Trial.

6

The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.

Vallejo A, Gutierrez C, Hernandez-Novoa B, Diaz L, Madrid N, Abad-Fernandez M, Dronda F, Perez-Elias MJ, Zamora J, Muñoz E, Muñoz-Fernandez MA, Moreno S. Vallejo A, et al. Among authors: moreno s. AIDS. 2012 Sep 24;26(15):1885-94. doi: 10.1097/QAD.0b013e3283584521. AIDS. 2012. PMID: 22992577 Clinical Trial.

7

The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression.

Serrano-Villar S, Gutiérrez C, Vallejo A, Hernández-Novoa B, Díaz L, Abad Fernández M, Madrid N, Dronda F, Zamora J, Muñoz-Fernández MÁ, Moreno S. Serrano-Villar S, et al. Among authors: moreno s. J Infect. 2013 Jan;66(1):57-66. doi: 10.1016/j.jinf.2012.09.013. Epub 2012 Oct 6. J Infect. 2013. PMID: 23046968

8

Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

Gutiérrez C, Hernández-Novoa B, Pérez-Elías MJ, Moreno AM, Holguín A, Dronda F, Casado JL, Moreno S. Gutiérrez C, et al. Among authors: moreno am, moreno s. HIV Clin Trials. 2013 Jan-Feb;14(1):10-6. doi: 10.1310/hct1401-10. HIV Clin Trials. 2013. PMID: 23372110

9

The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults.

Sainz T, Serrano-Villar S, Díaz L, González Tomé MI, Gurbindo MD, de José MI, Mellado MJ, Ramos JT, Zamora J, Moreno S, Muñoz-Fernández MA. Sainz T, et al. Among authors: moreno s. AIDS. 2013 Jun 1;27(9):1513-6. doi: 10.1097/QAD.0b013e32835faa72. AIDS. 2013. PMID: 23435292

10

Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.

Serrano-Villar S, Quereda C, Moreno A, Pérez-Elías MJ, Casado JL, Royuela A, Dronda F, Navas E, Hermida JM, Moreno S. Serrano-Villar S, et al. Among authors: moreno s, moreno a. Clin Infect Dis. 2013 Aug;57(3):458-64. doi: 10.1093/cid/cit221. Epub 2013 Apr 10. Clin Infect Dis. 2013. PMID: 23575196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,985 results

Search Page